Pictet Asset Management
UTHR icon

Pictet Asset Management’s United Therapeutics UTHR Stock Holding History

Pictet Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$145M Sell
267,852
-41,368
-13% -$23.3M 0.14% 173
2026
Q1 		$183M Buy
309,220
+2,383
+0.8% +$1.19M 0.19% 128
2025
Q4 		$150M Sell
306,837
-14,658
-5% -$6.83M 0.15% 166
2025
Q3 		$135M Buy
321,495
+110,078
+52% +$37M 0.13% 180
2025
Q2 		$60.7M Buy
211,417
+10,760
+5% +$3.22M 0.06% 290
2025
Q1 		$61.8M Buy
200,657
+82,566
+70% +$28.3M 0.07% 273
2024
Q4 		$41.7M Buy
118,091
+69,411
+143% +$25.5M 0.05% 337
2024
Q3 		$17.5M Sell
48,680
-8,832
-15% -$2.98M 0.02% 522
2024
Q2 		$18.3M Sell
57,512
-63,567
-53% -$16.8M 0.02% 484
2024
Q1 		$28.5M Sell
121,079
-32,104
-21% -$7.24M 0.03% 409
2023
Q4 		$33.7M Sell
153,183
-13,795
-8% -$3.18M 0.04% 366
2023
Q3 		$37.7M Buy
+166,978
New +$38.5M 0.05% 332

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Pictet Asset Management's UTHR Position: Q2 2026 in Review

Pictet Asset Management reduced its United Therapeutics (UTHR) stake by 13% in Q2 2026, selling an estimated $23.3M and leaving 267,852 shares worth $145M. The position accounts for 0.14% of the portfolio, ranked #173.

Pictet Asset Management first reported a position in UTHR in Q3 2023 and has held it in 12 quarters since. The position peaked at $183M in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Pictet Asset Management held 267,852 shares of United Therapeutics worth $145M as of Q2 2026.
  • Pictet Asset Management sold 41,368 United Therapeutics shares in Q2 2026, an estimated $23.3M.
  • United Therapeutics made up 0.14% of Pictet Asset Management's portfolio in Q2 2026, its #173 holding.
  • Pictet Asset Management first reported a position in United Therapeutics in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's United Therapeutics position peaked at $183M in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.